Latest University of Texas Stories

DALLAS, July 23, 2012 /PRNewswire/ -- Texas-based Southwest Airlines (NYSE: LUV) will become the Official Airline Sponsor of The University of Texas Athletics and the Ex-Students' Association of the University of Texas, the Texas Exes. The five-year partnership, brokered and managed by IMG College, the multimedia rights holder for Texas Athletics and the Texas Exes, kicks off in Fall 2012 with the Texas Football season and will continue throughout the year to support the Longhorns...

Michael Harper for redOrbit.com – Your Universe Online Like it or not, drones may be a very real part of our future -- regular drones, or civilian drones, as they’re called. Rather than being used to spy on our enemies, they’ll be used to deliver our packages and police our streets, and according to the FAA, there could be as many as 30,000 of these automated airborne vehicles before the end of the decade. So, when some University of Texas researchers were able to successfully...

Protein binds to growth factor receptor, priming it for normal function; Likely tie to 4 cancers Once considered merely a passive link between proteins that matter, Grb2 - pronounced "grab2" - actually lives up to its nickname with its controlling grip on an important cell signaling pathway, scientists at The University of Texas MD Anderson Cancer Center report in the June 22 issue of Cell. "Grb2 is a switch that controls normal signaling through the fibroblast growth factor receptor...

SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 4, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and The University of Texas MD Anderson Cancer Center today announced a non-exclusive research alliance for pre-clinical and clinical research to continue to understand the role that novel experimental therapies, including Onyx's carfilzomib and oprozomib, can play in the potential treatment of multiple myeloma and lymphoma. The term of the agreement extends for two years....

MATTHEWS, N.C., May 25, 2012 /PRNewswire/ -- CEM Corporation president and CEO Michael J. Collins delivered the commencement address for the University of Texas at Austin Chemistry and Biochemistry Department, which was held on May 18, 2012. Collins received his PhD in Physical Chemistry from the University and has been a member of the Advisory Board for the Chemistry Department at the school for a number of years. (Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b ) "I...

3-pronged study reveals high response rate in other advanced melanoma patients and activity in multiple cancers An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report in the May 18 issue of The Lancet. The drug dabrafenib, which targets the Val600 BRAF mutation that is active in half of melanoma cases, also cut the size of tumors in 25 of 36...

WORCESTER, Mass. and TORONTO, May 18, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) announced today that additional members have joined the Scientific Advisory Board (SAB) of its wholly-owned subsidiary, Antigen Express, Inc., for the company's AE37 breast cancer vaccine. The following distinguished scientists, scholars, and physicians join Dr. Gabriel N. Hortobagyi, MD, FACP (University of Texas MD Anderson Cancer Center), Dr. Kathy D. Miller, MD...

Novel adjuvant therapy shows promise for women with a history of breast cancer in Phase II clinical trial A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center. The findings, released today, will be presented on...

Cell surface protein blows potent cells' cover; targeted drug works in preclinical tests Breast cancer stem cells wear a cell surface protein that is part nametag and part bull's eye, identifying them as potent tumor-generating cells and flagging their vulnerability to a drug, researchers at The University of Texas MD Anderson Cancer Center report online in Journal of Clinical Investigation. "We've discovered a single marker for breast cancer stem cells and also found that it's...

CAMBRIDGE, Mass. and AUSTIN, Texas, April 27, 2012 /PRNewswire/ -- Zipcar, Inc. (Nasdaq: ZIP), the world's leading car-sharing network, along with City of Austin Austin Mayor Lee Leffingwell and Council Member Chris Riley, today announced a significant expansion of the Zipcar car sharing network into the City of Austin. The new program will provide Austin residents, visitors and businesses with increased access to convenient transportation options that reduce downtown parking...